tert-butyl N-[(1S,5R,6S)-5-(5-bromo-2-fluoro-3-pyridinyl)-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-yl]carbamate

C16H19BrFN3O3 — CID 90401312

IUPACtert-butyl N-[(1S,5R,6S)-5-(5-bromo-2-fluoro-3-pyridinyl)-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-yl]carbamate
SMILESCC(C)(C)OC(=O)NC1=N[C@@](C)(c2cc(Br)cnc2F)[C@@H]2C[C@@H]2O1
InChIInChI=1S/C16H19BrFN3O3/c1-15(2,3)24-14(22)20-13-21-16(4,9-6-11(9)23-13)10-5-8(17)7-19-12(10)18/h5,7,9,11H,6H2,1-4H3,(H,20,21,22)/t9-,11+,16-/m1/s1
InChIKeyMSDLWLHAUHMFDY-SEFYAATASA-N
MW400.25 g/mol
LogP3.50
Rot. Bonds1

About tert-butyl N-[(1S,5R,6S)-5-(5-bromo-2-fluoro-3-pyridinyl)-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-yl]carbamate

tert-butyl N-[(1S,5R,6S)-5-(5-bromo-2-fluoro-3-pyridinyl)-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-yl]carbamate (PubChem CID 90401312) has the molecular formula C16H19BrFN3O3 and a molecular weight of 400.25 g/mol. Its IUPAC name is tert-butyl N-[(1S,5R,6S)-5-(5-bromo-2-fluoro-3-pyridinyl)-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-yl]carbamate.

Molecular Properties

Compound Nametert-butyl N-[(1S,5R,6S)-5-(5-bromo-2-fluoro-3-pyridinyl)-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-yl]carbamate
PubChem CID90401312
Molecular FormulaC16H19BrFN3O3
Molecular Weight400.25 g/mol
Exact Mass399.06
IUPAC Nametert-butyl N-[(1S,5R,6S)-5-(5-bromo-2-fluoro-3-pyridinyl)-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-yl]carbamate
SMILESCC(C)(C)OC(=O)NC1=N[C@@](C)(c2cc(Br)cnc2F)[C@@H]2C[C@@H]2O1
InChIInChI=1S/C16H19BrFN3O3/c1-15(2,3)24-14(22)20-13-21-16(4,9-6-11(9)23-13)10-5-8(17)7-19-12(10)18/h5,7,9,11H,6H2,1-4H3,(H,20,21,22)/t9-,11+,16-/m1/s1
InChIKeyMSDLWLHAUHMFDY-SEFYAATASA-N
XLogP3.50
TPSA72.81 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds1
Heavy Atoms24
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500400.25
LogP ≤ 53.50
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Analyze tert-butyl N-[(1S,5R,6S)-5-(5-bromo-2-fluoro-3-pyridinyl)-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-yl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of tert-butyl N-[(1S,5R,6S)-5-(5-bromo-2-fluoro-3-pyridinyl)-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-yl]carbamate?
The IUPAC name of tert-butyl N-[(1S,5R,6S)-5-(5-bromo-2-fluoro-3-pyridinyl)-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-yl]carbamate (CID 90401312) is tert-butyl N-[(1S,5R,6S)-5-(5-bromo-2-fluoro-3-pyridinyl)-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-yl]carbamate.
What is the SMILES notation for tert-butyl N-[(1S,5R,6S)-5-(5-bromo-2-fluoro-3-pyridinyl)-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-yl]carbamate?
The canonical SMILES for tert-butyl N-[(1S,5R,6S)-5-(5-bromo-2-fluoro-3-pyridinyl)-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-yl]carbamate is CC(C)(C)OC(=O)NC1=N[C@@](C)(c2cc(Br)cnc2F)[C@@H]2C[C@@H]2O1.
What is the InChIKey of tert-butyl N-[(1S,5R,6S)-5-(5-bromo-2-fluoro-3-pyridinyl)-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-yl]carbamate?
The InChIKey is MSDLWLHAUHMFDY-SEFYAATASA-N. The full InChI is InChI=1S/C16H19BrFN3O3/c1-15(2,3)24-14(22)20-13-21-16(4,9-6-11(9)23-13)10-5-8(17)7-19-12(10)18/h5,7,9,11H,6H2,1-4H3,(H,20,21,22)/t9-,11+,16-/m1/s1.
What are the key properties of tert-butyl N-[(1S,5R,6S)-5-(5-bromo-2-fluoro-3-pyridinyl)-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-yl]carbamate?
tert-butyl N-[(1S,5R,6S)-5-(5-bromo-2-fluoro-3-pyridinyl)-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-yl]carbamate has a molecular weight of 400.25 g/mol, XLogP of 3.50, 1 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for tert-butyl N-[(1S,5R,6S)-5-(5-bromo-2-fluoro-3-pyridinyl)-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-3-yl]carbamate is sourced from PubChem (CID 90401312), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).